| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 481.48M | 586.71M | 472.63M | 499.85M | 517.25M |
| Gross Profit | 221.17M | 259.32M | 229.76M | 196.22M | 195.89M |
| EBITDA | 12.34M | 94.41M | 101.71M | 31.62M | -49.80M |
| Net Income | -124.77M | -40.04M | 5.03M | -53.37M | -184.88M |
Balance Sheet | |||||
| Total Assets | 811.95M | 867.60M | 772.59M | 759.45M | 812.02M |
| Cash, Cash Equivalents and Short-Term Investments | 13.13M | 8.54M | 38.10M | 10.26M | 47.11M |
| Total Debt | 649.20M | 566.51M | 488.68M | 477.58M | 544.81M |
| Total Liabilities | 732.68M | 664.28M | 572.38M | 560.04M | 615.61M |
| Stockholders Equity | 79.28M | 203.32M | 200.21M | 199.41M | 196.42M |
Cash Flow | |||||
| Free Cash Flow | 21.48M | 75.88M | 110.63M | 101.67M | 208.59M |
| Operating Cash Flow | 23.98M | 82.01M | 112.24M | 102.89M | 213.70M |
| Investing Cash Flow | -11.36M | -8.01M | -1.58M | -1.12M | -3.02M |
| Financing Cash Flow | -5.82M | -105.15M | -79.00M | -142.37M | -193.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$498.20M | 5.29 | 16.67% | 8.33% | 21.99% | 11.36% | |
69 Neutral | HK$292.48M | 9.71 | 3.92% | 10.32% | -6.67% | -29.55% | |
63 Neutral | HK$116.00M | 12.60 | 1.89% | ― | -20.10% | -74.16% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
49 Neutral | HK$232.55M | -5.88 | -27.00% | ― | 10.42% | 11.14% | |
45 Neutral | HK$137.00M | -9.02 | 2.37% | ― | -1.65% | 230.00% | |
39 Underperform | HK$75.54M | -0.50 | -194.50% | ― | -17.91% | -32.66% |